Page last updated: 2024-10-20

pyridoxamine and Degenerative Disc Disease

pyridoxamine has been researched along with Degenerative Disc Disease in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Levels of blood glycation and disc degeneration were investigated."1.56Advanced Glycation End Product Inhibitor Pyridoxamine Attenuates IVD Degeneration in Type 2 Diabetic Rats. ( Avalos, P; Bae, HW; Glaeser, JD; Ju, D; Kaneda, G; Kanim, LEA; Metzger, MF; Salehi, K; Sheyn, D; Stefanovic, T; Stephan, S; Tawackoli, W; Yang, JH, 2020)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Glaeser, JD1
Ju, D1
Tawackoli, W1
Yang, JH1
Salehi, K1
Stefanovic, T1
Kanim, LEA1
Avalos, P1
Kaneda, G1
Stephan, S1
Metzger, MF1
Bae, HW1
Sheyn, D1
Illien-Junger, S1
Grosjean, F1
Laudier, DM1
Vlassara, H1
Striker, GE1
Iatridis, JC1

Other Studies

2 other studies available for pyridoxamine and Degenerative Disc Disease

ArticleYear
Advanced Glycation End Product Inhibitor Pyridoxamine Attenuates IVD Degeneration in Type 2 Diabetic Rats.
    International journal of molecular sciences, 2020, Dec-19, Volume: 21, Issue:24

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat;

2020
Combined anti-inflammatory and anti-AGE drug treatments have a protective effect on intervertebral discs in mice with diabetes.
    PloS one, 2013, Volume: 8, Issue:5

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Diabetes Mellitus, Experimental; Disease Mo

2013